TASLY(SH:600535) Xin Hua Cai Jing·2025-09-22 08:45Core Insights - Tianshili's "Jiangcha" has released the first human clinical trial report for sugar-free tea in China, marking a significant step from conceptual consumption to scientific and standardized development in the sugar-free tea beverage sector [2][4] - The company has filled a research gap in the domestic market by completing a scientific validation process for sugar-free tea, which has been lacking in evidence-based research and standardized verification compared to Japan [3][4] Research and Development - Tianshili's "Jiangcha" has successfully completed both animal and human clinical trials, establishing a complete scientific loop from basic experiments to clinical validation, thus filling a research void in the field [4][9] - The animal trials involved a 16-week study on male SD rats, using a high-fructose high-fat diet to induce metabolic syndrome, with various intervention groups to assess the effects of tea polyphenols [5][6] Clinical Trial Results - The human clinical trial was designed as a randomized, open-label, controlled study with 72 participants, showing significant improvements in blood sugar and lipid levels after consuming high doses of tea polyphenols [7][12] - Results indicated that the "Jiangcha" group had statistically significant lower postprandial blood sugar levels compared to the control group, confirming its effectiveness in inhibiting post-meal blood sugar spikes [12] Key Ingredients - The core component of Tianshili's "Jiangcha" is tea polyphenols, which have been recognized for their role in regulating sugar and lipid metabolism, improving gut microbiota, and maintaining overall health [13] - Recent studies have highlighted the mechanisms through which tea polyphenols exert their effects, including modulation of gut microbiota and activation of specific metabolic pathways [13] Future Directions - Tianshili aims to continue its research on sugar and lipid metabolism, focusing on the development of health products based on evidence and scientific validation [15] - The company is committed to leveraging its extensive pharmaceutical research experience to innovate in the health product sector, aspiring to become a leader in the global market for sugar and lipid metabolism management [15]